Cargando…
Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy
Only few prospective cohort trials have evaluated the risk factors for the 2-year mortality rate between two patient subgroups with locally advanced head and neck squamous cell carcinoma (LAHNSCC): oral cavity cancer with adjuvant concurrent chemoradiotherapy (CCRT) (OCC) and non-oral cavity cancer...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962429/ https://www.ncbi.nlm.nih.gov/pubmed/35203597 http://dx.doi.org/10.3390/biomedicines10020388 |
_version_ | 1784677801990815744 |
---|---|
author | Lin, Yu-Ching Wang, Cheng-Hsu Ling, Hang Huong Pan, Yi-Ping Chang, Pei-Hung Chou, Wen-Chi Chen, Fang-Ping Yeh, Kun-Yun |
author_facet | Lin, Yu-Ching Wang, Cheng-Hsu Ling, Hang Huong Pan, Yi-Ping Chang, Pei-Hung Chou, Wen-Chi Chen, Fang-Ping Yeh, Kun-Yun |
author_sort | Lin, Yu-Ching |
collection | PubMed |
description | Only few prospective cohort trials have evaluated the risk factors for the 2-year mortality rate between two patient subgroups with locally advanced head and neck squamous cell carcinoma (LAHNSCC): oral cavity cancer with adjuvant concurrent chemoradiotherapy (CCRT) (OCC) and non-oral cavity cancer with primary CCRT (NOCC), under the recommended calorie intake and investigated the interplay among calorie supply, nutrition–inflammation biomarkers (NIBs), and total body composition change (TBC), as assessed using dual-energy X-ray absorptiometry (DXA). Patients with LAHNSCC who consumed at least 25 kcal/kg/day during CCRT were prospectively recruited. Clinicopathological variables, blood NIBs, CCRT-related factors, and TBC data before and after treatment were collected. Factor analysis was performed to reduce the number of anthropometric and DXA-derived measurements. Cox proportional hazards models were used for analysis. We enrolled 123 patients with LAHNSCC (69 with OCC and 54 with NOCC). The mean daily calorie intake correlated with the treatment interval changes in total body muscle and fat. Patients consuming ≥30 kcal/kg/day had lower pretreatment levels but exhibited fewer treatment interval changes in anthropometric and DXA measurements than patients consuming <30 kcal/kg/day. In the multivariate analysis of the 2-year mortality rate, the prognostic influence of the recommended calorie intake could not be confirmed, but different risk factors (performance status, pretreatment platelet-to-lymphocyte ratio, and treatment interval body muscle changes in patients with OCC; age, pretreatment neutrophil-to-lymphocyte ratio, and body fat storage in patients with NOCC) showed independent effects. Therefore, the inflammation status and body composition, but not the recommended calorie supply, contribute to the 2-year mortality rate for patients with LAHNSCC receiving CCRT. |
format | Online Article Text |
id | pubmed-8962429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89624292022-03-30 Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy Lin, Yu-Ching Wang, Cheng-Hsu Ling, Hang Huong Pan, Yi-Ping Chang, Pei-Hung Chou, Wen-Chi Chen, Fang-Ping Yeh, Kun-Yun Biomedicines Article Only few prospective cohort trials have evaluated the risk factors for the 2-year mortality rate between two patient subgroups with locally advanced head and neck squamous cell carcinoma (LAHNSCC): oral cavity cancer with adjuvant concurrent chemoradiotherapy (CCRT) (OCC) and non-oral cavity cancer with primary CCRT (NOCC), under the recommended calorie intake and investigated the interplay among calorie supply, nutrition–inflammation biomarkers (NIBs), and total body composition change (TBC), as assessed using dual-energy X-ray absorptiometry (DXA). Patients with LAHNSCC who consumed at least 25 kcal/kg/day during CCRT were prospectively recruited. Clinicopathological variables, blood NIBs, CCRT-related factors, and TBC data before and after treatment were collected. Factor analysis was performed to reduce the number of anthropometric and DXA-derived measurements. Cox proportional hazards models were used for analysis. We enrolled 123 patients with LAHNSCC (69 with OCC and 54 with NOCC). The mean daily calorie intake correlated with the treatment interval changes in total body muscle and fat. Patients consuming ≥30 kcal/kg/day had lower pretreatment levels but exhibited fewer treatment interval changes in anthropometric and DXA measurements than patients consuming <30 kcal/kg/day. In the multivariate analysis of the 2-year mortality rate, the prognostic influence of the recommended calorie intake could not be confirmed, but different risk factors (performance status, pretreatment platelet-to-lymphocyte ratio, and treatment interval body muscle changes in patients with OCC; age, pretreatment neutrophil-to-lymphocyte ratio, and body fat storage in patients with NOCC) showed independent effects. Therefore, the inflammation status and body composition, but not the recommended calorie supply, contribute to the 2-year mortality rate for patients with LAHNSCC receiving CCRT. MDPI 2022-02-06 /pmc/articles/PMC8962429/ /pubmed/35203597 http://dx.doi.org/10.3390/biomedicines10020388 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Lin, Yu-Ching Wang, Cheng-Hsu Ling, Hang Huong Pan, Yi-Ping Chang, Pei-Hung Chou, Wen-Chi Chen, Fang-Ping Yeh, Kun-Yun Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy |
title | Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy |
title_full | Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy |
title_fullStr | Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy |
title_full_unstemmed | Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy |
title_short | Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy |
title_sort | inflammation status and body composition predict two-year mortality of patients with locally advanced head and neck squamous cell carcinoma under provision of recommended energy intake during concurrent chemoradiotherapy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962429/ https://www.ncbi.nlm.nih.gov/pubmed/35203597 http://dx.doi.org/10.3390/biomedicines10020388 |
work_keys_str_mv | AT linyuching inflammationstatusandbodycompositionpredicttwoyearmortalityofpatientswithlocallyadvancedheadandnecksquamouscellcarcinomaunderprovisionofrecommendedenergyintakeduringconcurrentchemoradiotherapy AT wangchenghsu inflammationstatusandbodycompositionpredicttwoyearmortalityofpatientswithlocallyadvancedheadandnecksquamouscellcarcinomaunderprovisionofrecommendedenergyintakeduringconcurrentchemoradiotherapy AT linghanghuong inflammationstatusandbodycompositionpredicttwoyearmortalityofpatientswithlocallyadvancedheadandnecksquamouscellcarcinomaunderprovisionofrecommendedenergyintakeduringconcurrentchemoradiotherapy AT panyiping inflammationstatusandbodycompositionpredicttwoyearmortalityofpatientswithlocallyadvancedheadandnecksquamouscellcarcinomaunderprovisionofrecommendedenergyintakeduringconcurrentchemoradiotherapy AT changpeihung inflammationstatusandbodycompositionpredicttwoyearmortalityofpatientswithlocallyadvancedheadandnecksquamouscellcarcinomaunderprovisionofrecommendedenergyintakeduringconcurrentchemoradiotherapy AT chouwenchi inflammationstatusandbodycompositionpredicttwoyearmortalityofpatientswithlocallyadvancedheadandnecksquamouscellcarcinomaunderprovisionofrecommendedenergyintakeduringconcurrentchemoradiotherapy AT chenfangping inflammationstatusandbodycompositionpredicttwoyearmortalityofpatientswithlocallyadvancedheadandnecksquamouscellcarcinomaunderprovisionofrecommendedenergyintakeduringconcurrentchemoradiotherapy AT yehkunyun inflammationstatusandbodycompositionpredicttwoyearmortalityofpatientswithlocallyadvancedheadandnecksquamouscellcarcinomaunderprovisionofrecommendedenergyintakeduringconcurrentchemoradiotherapy |